Scilex Holding (SCLXW) Notes Payables (2020 - 2025)

Scilex Holding (SCLXW) recorded quarterly Notes Payables of $800000.0 in Q3 2025, down 95.92% quarter-over-quarter from $19.6 million in Q4 2021.

Scilex Holding (SCLXW) Notes Payables (2020 - 2025) Analysis & Trends

Scilex Holding's Notes Payables history runs 3 years deep, the most recent figure standing at $800000.0 for Q3 2025.

In Q3 2025, Notes Payables changed N/A year-over-year to $800000.0; the TTM figure through Sep 2025 stood at $800000.0 (changed N/A YoY), while the FY2021 annual figure was $19.6 million, up 15586.4% from the prior year.
Notes Payables was $800000.0 for Q3 2025 at Scilex Holding, down from $19.6 million in the prior quarter.
In the past five years, Notes Payables ranged from a high of $19.6 million in Q4 2021 to a low of $800000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn
10	Scilex Holding	-	-	4.15 Mn

Download Data